Statins
Sort by:
MUSC Cardiology
Clear Outcomes - The First (and Only) Trial in Statin Intolerant Patients
FEATURING
Matthew Budoff
- 3,286 views
- March 29, 2024
- 19
Cedars Sinai
Somethings Old, Somethings New: Cholesterol Management in 2024
FEATURING
Martha Gulati
- 2,776 views
- June 4, 2024
- 20
Complex Coronary Cases
Lp(a): The New Kid on the Block
FEATURING
Pam Taub
- 2,614 views
- August 31, 2023
- 21
Right Care Initiative
How Can CAC Testing Be Used to Inform the Use of Statin and Non-Statin Therapies to Reduce ASCVD Risk?
FEATURING
Donald M. Lloyd-Jones
- 2,734 views
- June 4, 2024
- 19
Keck School of Medicine of USC
Role of Lipoprotein(a) in Coronary Disease: What CV Risks Can you Expect? How to Manage the Condition?
FEATURING
Steven Nissen
- 947 views
- January 5, 2021
- 13
Scripps Health
Non-Statin Pharmacotherapies for Risk Reduction
FEATURING
Michael Wilkinson
- 3,421 views
- June 28, 2022
- 13
Penn Medicine Heart and Vascular Center
Anti-Inflammatory Therapies in Cardiovascular Diseases
FEATURING
Antonio Abbate
- 2,583 views
- February 1, 2024
- 18
Michael Ozner
The Role of Omega-3 Fatty Acids for the Treatment and Prevention of Cardiometabolic Disease
- 2,598 views
- May 9, 2018
- 17
Complex Coronary Cases
Role of Triglycerides & More
FEATURING
Robert Rosenson
- 2,762 views
- August 31, 2023
- 16
Precision Cardiovascular Care 2024: Transitioning Care from Phenotypes to Genotypes
Lipoprotein(a) in 2024
FEATURING
Harpreet Bhatia
- 407 views
- May 17, 2024
- 6
Top Ten Topics in Clinical Cardiology 2022
What’ll be New in Lipid Management in 2023? Rethinking the Paradigms
FEATURING
Robert Rosenson
- 3,192 views
- November 21, 2022
- 10
ASPC 2019 Congress on CVD Prevention
LDL-C lowering and the Brain: Differentiating Fact from Fiction
FEATURING
Peter Toth
- 688 views
- August 9, 2019
- 8
Cardiometabolic Health Congress (CMHC)
ASCVD Risk Assessment and Prevention: Where Do We Stand Now?
FEATURING
Salim Virani
- 1,174 views
- July 23, 2022
- 13
The Texas Heart Institute
Non-Statin Therapies for LDL-C Lowering: How to Rationally Use Them?
FEATURING
Salim Virani
- 2,197 views
- November 12, 2021
- 15
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Novelties in Lipid Lowering Therapies: Can Statin Therapy Reduce Residual Risk? How Promising Are Icosapent Ethyl, Bampedoic Acid, Inclisiran and Evinacumab for Treating the Patients?
FEATURING
Pam Taub
- 924 views
- February 5, 2021
- 11
ASPC 2018 Congress on CVD Prevention
Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Higher CVD Risk
FEATURING
Patrick Moriarty
- 834 views
- August 10, 2018
- 10
Canadian Collaborative Research Network
The Disruptive Science of LDL-Lowering: From Statins to PCSK9 Manipulation
FEATURING
Milan Gupta
- 1,561 views
- May 14, 2024
- 13
Canadian Collaborative Research Network
State of the Heart 2023 Session 2 Panel Discussion
- 68 views
- July 26, 2023
- 1
Michigan Medicine
Updates in Lipid Management
FEATURING
Scott L. Hummel
- 1,821 views
- August 28, 2024
- 14
Complex Coronary Cases
Eliminating Coronary Artery Disease
FEATURING
Marc Sabatine
- 1,193 views
- August 31, 2023
- 10
Society for Cardiovascular Angiography & Interventions (SCAI)
Addressing Gaps in ASCVD Care: SCAI Secondary Prevention Toolkit
FEATURING
Timir Paul
- 69 views
- July 30, 2024
- 1
The Texas Heart Institute
Updates in Guidelines for the Management of Chronic Coronary Artery Disease: What We Should Pay Closer Attention To
FEATURING
Salim Virani
- 913 views
- March 15, 2024
- 10
